Briest, Franziska http://orcid.org/0000-0001-5969-9467
Noerenberg, Daniel
Hennch, Cornelius http://orcid.org/0000-0003-4104-5531
Yoshida, Kenichi http://orcid.org/0000-0003-4612-2778
Hablesreiter, Raphael http://orcid.org/0000-0002-4586-932X
Nimo, Jose
Sasca, Daniel http://orcid.org/0000-0003-0330-7959
Kirchner, Marieluise
Mansouri, Larry
Inoue, Yoshikage
Wiegand, Laura http://orcid.org/0000-0002-9917-7396
Staiger, Annette M. http://orcid.org/0000-0002-5896-3200
Casadei, Beatrice
Korkolopoulou, Penelope
Weiner, January http://orcid.org/0000-0003-1438-7819
Lopez-Guillermo, Armando
Warth, Arne
Schneider, Tamás
Nagy, Ákos http://orcid.org/0000-0001-6118-0365
Klapper, Wolfram
Hummel, Michael http://orcid.org/0000-0001-6717-605X
Kanellis, George
Anagnostopoulos, Ioannis http://orcid.org/0000-0002-5043-6043
Mertins, Philipp
Bullinger, Lars
Rosenquist, Richard http://orcid.org/0000-0002-0211-8788
Vassilakopoulos, Theodoros P.
Ott, German
Ogawa, Seishi http://orcid.org/0000-0002-7778-5374
Damm, Frederik http://orcid.org/0000-0001-5553-1173
Funding for this research was provided by:
Deutsche Krebshilfe
Article History
Received: 18 January 2023
Revised: 15 August 2023
Accepted: 22 August 2023
First Online: 30 August 2023
Competing interests
: FB received honoraria from Ipsen Pharma and funding from Novartis, both unrelated to the project. DN received honoraria from Incyte Biosciences and Gilead. RR received honoraria from AbbVie, AstraZeneca, Janssen, Illumina and Roche. LB has received honoraria from AbbVie, Amgen, Astellas, BristolMyers Squibb, Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Roche, Sanofi, and Seattle Genetics, and has received research support from Bayer and Jazz Pharmaceuticals. FD reports personal fees from AbbVie, AstraZeneca, Gilead, Incyte, Novartis, and Roche outside the submitted work. The other authors declare that they have no competing financial interests.